Describing Drugs: A Response to Profs. Allison and Ouellette
Sherkow, Jacob S.
Loading…
Permalink
https://hdl.handle.net/2142/110298
Description
Title
Describing Drugs: A Response to Profs. Allison and Ouellette
Author(s)
Sherkow, Jacob S.
Issue Date
2016-03-23
Keyword(s)
patents
intellectual property
ip
PTO
drugs
pharmaceuticals
bioscience
biotechnology
law
Allison
Ouellette
written description
112
empirical
doctrinal
Abstract
Profs. Allison and Ouellette’s Article, How Courts Adjudicate Patent Definiteness and Disclosure, 65 Duke L.J. 609 (2015), on courts’ adjudication of certain patent disputes presents some surprising data: pharmaceutical patents litigated to judgment fare substantially worse on written-description analyses if they are not part of traditional pioneer-generic litigation. This Response engages in several hypotheses for this disparity and examines the cases that make up Allison and Ouellette’s dataset. An analysis of these cases finds that the disparity can be best explained by technological and judicial idiosyncrasies in each case, rather than larger differences among pharmaceutical patent cases. This finding contextualizes the power and limits of large-scale empirical patent scholarship, like Allison and Ouellette’s, and provides of model for how empirical and doctrinal patent scholarship can complement one another.
This is the default collection for all research and scholarship developed by faculty, staff, or students at the University of Illinois at Urbana-Champaign
Use this login method if you
don't
have an
@illinois.edu
email address.
(Oops, I do have one)
IDEALS migrated to a new platform on June 23, 2022. If you created
your account prior to this date, you will have to reset your password
using the forgot-password link below.